"Designing Growth Strategies is in our DNA"

Oligonucleotide Synthesis Market Size, Share and Global Trend By Products (Drugs, Probes, Linkers, Adapters, Reagents, Others), By Application (DNA Sequencing and Amplification (PCR), Detecting Complementary DNA or RNA Via Hybridization, Synthesis of Artificial Genes, Genetic Mutations, Others), By End User (Research Institutes, Diagnostic Laboratories, Pharmaceuticals Industries, Biotechnology Companies), and Geography Forecast till 2022-2029

Region : Global | Report ID: FBI101020 | Status : Ongoing

 

KEY MARKET INSIGHTS

Chemical synthesis of short fragments of nucleic acids is defined as oligonucleotide synthesis. Oligonucleotide synthesis provides many applications such a DNA sequencing, synthesis of artificial genes, and diagnostics of many diseases associated with a genetic mutation. Developments in oligonucleotide synthesis and growing research activities in synthetic as well as biology sector are some of the factors driving the global oligonucleotide synthesis market growth.

The more prominent use of DNA microarray technology with the use of oligonucleotide for diagnostics therapeutics and new microchip-based oligonucleotide synthesis has reduced the cost of synthesis of the oligonucleotide, and these factors are anticipated to boost the global oligonucleotide synthesis market growth during the projected period.

To gain extensive insights into the market, Request for Customization


Oligonucleotide synthesis market growth is being driven by growing research activities, many strong pipeline candidates, and growing actuations and partnerships of may pharmaceutical companies and research institutes. For instance, in 2017, CordenPharma International signed an agreement with GE Healthcare Dharmacon Inc. for the development of an end-to-end oligonucleotide-based drug discovery solution. Also, reduction in the cost of sequencing and advent of novel techniques in oligonucleotide synthesis is anticipated to enhance the growth in oligonucleotide synthesis market during the forecast period.


However, the lack of funding in research and development sectors in the emerging nations is likely to hamper the oligonucleotide synthesis market growth during the forecast period.


Key Players Covered


Some of the major companies that are present in the global oligonucleotide synthesis market report include Agilent Technologies., ATDBio Ltd., Eurofins Genomics., Eurogentec., Genscript, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, Nitto Denko Avecia, Thermo Fisher Scientific and others.


SEGMENTATION


























SEGMENTATION



 DETAILS



By Products



· Drugs


· Probes


· Linkers


· Adapters


· Reagents


· Others



By Application



• DNA Sequencing and Amplification (PCR)


• Detecting Complementary DNA or RNA Via Hybridization


• Synthesis of Artificial Genes


• Genetic Mutations


• Others



By End User



• Research Institutes


• Diagnostic Laboratories


• Pharmaceuticals Industries


• Biotechnology Companies


• Others



By Geography



· North America (U.S. and Canada)


· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)


· Latin America (Brazil, Mexico, and Rest of Latin America)


· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



 As per the oligonucleotide synthesis market trends, oligonucleotide drugs among product segmentation are anticipated to hold the largest market share in the forecast period as they can target specific genes, which help in the development of personalized medicine.


Key Insights



  • Overview of Advancement in Oligonucleotide Synthesis

  • Overview of Pipeline Products

  • Pricing Analysis

  • The Regulatory Scenario for Key Countries/Regions

  • Key Industry Developments –Mergers, Acquisitions, and Partnerships


Regional Analysis


The global oligonucleotide synthesis market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global oligonucleotide synthesis market during the projected period owing to the emerging guidelines, high investments in research activities in the development of novel oligonucleotides, and growing adoption of novel technologies. In Asia Pacific the global oligonucleotide synthesis market is anticipated to grow at a significant rate during the forecast period owing to the growing demand of diagnostic tools and rising awareness of the emerging oligonucleotide synthesis technique by many research organizations.


Oligonucleotide Market Industry Developments



  • In October 2018, DIA/FDA Oligonucleotide- based therapeutics conference was held in North Bethesda, that addressed on the quality risk management, manufacturing advances, specifications, formulation issues, oligonucleotide pharmacokinetics, nonclinical assessments in support of drug development and clinical advances in therapeutic targets, trial design and safety for antisense, siRNA, mRNA and microRNA therapies.
  • In September 2018, 14th annual meeting of the Oligonucleotide Therapeutics Society took place in Seattle [providing data on the therapeutic applications of oligonucleotides.

  • Ongoing
  • 2021
  • 2018-2020

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

iqvia
Ipsos
Grifols
Fresenius
Galemed

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X